Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 03, 2015	Sep. 27, 2014
Cash flows from operating activities:
Net earnings	$ 424,981	$ 385,174
Adjustments to reconcile net earnings to net cash provided by operating activities:
Restructuring	18,716	14,078
Depreciation and amortization	268,622	249,905
Deferred income taxes	(35,171)	(44,842)
Loss on extinguishment of debt	0	16,530
Loss on disposal of property, plant and equipment	349	511
Stock-based compensation expense	24,488	21,497
Changes in operating assets and liabilities, net of effects of acquisitions:
Receivables, net	(147,213)	(187,243)
Inventories	(3,219)	(108,875)
Accounts payable and accrued expenses	146,025	20,911
Other assets and prepaid expenses	(101,466)	(28,266)
Other liabilities	60,840	(15,957)
Net cash provided by operating activities	656,952	323,423
Cash flows from investing activities:
Additions to property, plant and equipment	(352,070)	(391,580)
Acquisitions, net of cash acquired	(1,211,715)	19
Net cash used in investing activities	(1,563,785)	(391,561)
Cash flows from financing activities:
Payments on Senior Credit Facilities	(1,087,338)	(1,399,286)
Proceeds from Senior Credit Facilities	1,057,661	1,048,237
Payments on Commercial Paper	(13,456,251)	(4,589,051)
Proceeds from Commercial Paper	13,856,454	5,158,101
Repayment of senior notes	0	(200,000)
Proceeds from 2.00% Senior Notes	564,653	0
Payments of acquired debt and other financings	(9,321)	(39,921)
Change in asset securitization borrowings, net	0	200,000
Payments on other debt	0	(52,920)
Debt issuance costs	(6,859)	0
Debt extinguishment costs	0	(15,450)
Change in outstanding checks in excess of cash	1,709	5,327
Proceeds and net tax benefit from stock transactions	9,798	11,550
Net cash provided by financing activities	930,506	126,587
Effect of exchange rate changes on cash and cash equivalents	(10,834)	(6,946)
Net change in cash and cash equivalents	12,839	51,503
Cash and cash equivalents, beginning of period	97,877	54,066
Cash and cash equivalents, end of period	$ 110,716	$ 105,569